MedTrace Logo

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

NCT06557148 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of this study to compare two types of cancer imaging scans to see which is better at detecting and monitoring metastatic ILC. This study will compare PET/CT (positron emission tomography/computed tomography) scans using the radiotracer fluorine 18 (18F)-fluoroestradiol (FES) with a standard imaging approach for detecting and monitoring ILC, PET/CT scans using the radiotracer 18F-fluorodeoxyglucose (FDG). These scans will be referred to as FES PET/CT scans and FDG PET/CT scans.

Conditions

Interventions

DIAGNOSTIC_TEST

18F-Fluoroestradiol PET/CT

Scanned at baseline and again posttreatment within 2 weeks of the restaging FDG PET/CT

Sponsors & Collaborators

Principal Investigators

  • Somali Gavane, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-13
Primary Completion
2027-08-13
Completion
2027-08-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06557148 on ClinicalTrials.gov